Chemistry Wealth Management’s Ameriprise Financial AMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Sell
3,721
-26
-0.7% -$11.9K 0.27% 58
2026
Q1
$1.67M Hold
3,747
0.29% 53
2025
Q4
$1.84M Sell
3,747
-44
-1% -$20.9K 0.34% 46
2025
Q3
$1.86M Sell
3,791
-19
-0.5% -$9.74K 0.36% 48
2025
Q2
$2.03M Hold
3,810
0.44% 37
2025
Q1
$1.84M Hold
3,810
0.43% 39
2024
Q4
$2.03M Buy
3,810
+114
+3% +$60.8K 0.48% 34
2024
Q3
$1.74M Hold
3,696
0.41% 40
2024
Q2
$1.58M Buy
3,696
+190
+5% +$81.2K 0.41% 42
2024
Q1
$1.54M Sell
3,506
-82
-2% -$32.8K 0.41% 42
2023
Q4
$1.36M Hold
3,588
0.41% 42
2023
Q3
$1.18M Sell
3,588
-142
-4% -$48.5K 0.39% 45
2023
Q2
$1.24M Hold
3,730
0.4% 43
2023
Q1
$1.14M Sell
3,730
-88
-2% -$28.8K 0.4% 45
2022
Q4
$1.19M Hold
3,818
0.46% 43
2022
Q3
$962K Hold
3,818
0.38% 46
2022
Q2
$907K Hold
3,818
0.35% 54
2022
Q1
$1.15M Buy
+3,818
New +$1.15M 0.39% 46

Other funds holding AMP

Chemistry Wealth Management's AMP Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Ameriprise Financial (AMP) stake by 0.69% in Q2 2026, selling an estimated $11.9K and leaving 3,721 shares worth $1.71M. The position accounts for 0.27% of the portfolio, ranked #58.

Chemistry Wealth Management first reported a position in AMP in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.03M in Q2 2025. 348 funds tracked by Wall St. Rank hold AMP as of Q2 2026.

  • Chemistry Wealth Management held 3,721 shares of Ameriprise Financial worth $1.71M as of Q2 2026.
  • Chemistry Wealth Management sold 26 Ameriprise Financial shares in Q2 2026, an estimated $11.9K.
  • Ameriprise Financial made up 0.27% of Chemistry Wealth Management's portfolio in Q2 2026, its #58 holding.
  • Chemistry Wealth Management first reported a position in Ameriprise Financial in Q1 2022 and has held it in 18 quarters since.
  • Chemistry Wealth Management's Ameriprise Financial position peaked at $2.03M in Q2 2025.
  • 348 funds tracked by Wall St. Rank held Ameriprise Financial as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.